The programme will be updated regularly on this page. Keep an eye on this page and the main coference page for more incredible keynote and snapshot speakers and their information!
UPM Biomedicals 8th Annual Conference
DAY 1: Wednesday, October 26th – 3D in vitro models and their automation for HTS/HCS
DAY 2: Thursday 27th – regenerative medicine and the development of advanced therapies
Dr. Toni T. Seppälä graduated from medical school as licentiate of medicine in the University of Eastern Finland in 2010 and defended his PhD thesis on Alzheimer’s disease in 2012. During surgery residency with professor Jukka-Pekka Mecklin’s mentorship he became interested in cancer research.
In 2019–2021 Dr. Seppälä underwent a research fellowship at the department of Surgical Oncology in the Johns Hopkins University and Sidney Kimmel Comprehensive Cancer Center in Baltimore, MD, USA, under supervision of pancreatic surgeons Dr. Richard Burkhart and Dr. Christopher Wolfgang.
In 2022, he was appointed as a tenure track professor of cancer research in University of Tampere and leads laboratories and research groups in Tampere and Helsinki Universities.
He serves on the board of Directors of the European Hereditary Tumour Group, the scientific committee of the Prospective Lynch Syndrome Database, and as a Secretary of the Finnish Society of Surgery.
Dr. Seppälä has published over 100 articles, opinions, podcasts and interviews with >3000 citations, and raised over 2.2M euros of competed research funding.
The majority of Dr. Seppälä’s research have been from the field of hereditary cancer, colorectal cancer and pancreatic cancer, and he is appreciated as an expert especially in Lynch Syndrome. His current interests in cancer research are in personalized medicine utilizing precision technologies in solid tumors, such as genomics, patient-derived organoids and cell-free DNA.
He has worked as a colorectal surgeon since board certification in 2018, and was appointed as associate professor at Uni. Helsinki in 2019.
Pia R-M Siljander studied biochemistry during her Masters at the University of Helsinki and at the Wihuri Research Institute during her PhD with focus on collagen receptor interplay in platelet activation, she started her ongoing work on microparticles, a subset of extracellular vesicles (EVs). After PhD completion, she did a Postdoc at the University of Cambridge, U.K. For more than 15 years, she has been working at the University of Helsinki, now as a senior university lecturer at the Faculty of Biological and Environmental Sciences, Molecular and Integrative Biosciences research program. As the principal investigator of EV research group from 2011-, her continuing interest is to understand the biophysical and functional versatility of platelet and cancer EVs and to develop the methodologies in the EV field. The latter manifested in the establishment of the world’s first extracellular core facility for EVs in 2016. Her projects are driven both academically and through industry-collaboration. She is the vice president of the Finnish Extracellular Society (FISEV).
Tijmen is senior screening specialist at the ETH Zurich core facility NEXUS Personalized Health Technologies in Switzerland. He develops high-throughput screening assays with a particular focus on assay miniaturization for advanced cell systems. Tijmen studied bio-pharmaceutical sciences at Leiden University in the Netherlands, where he also obtained his PhD degree. During his studies, he used lab-automation equipment and 3D-cell culture models to develop and optimize high-throughput and high-content screening assays.
Akihiro J. Matsuoka is an assistant professor in the Otolaryngology-Head and Neck Surgery department at Feinberg School of Medicine, Northwestern University. He is also a faculty at the Department of Communication Sciences and Disorders and the Center for Advanced Regenerative Engineering, Northwestern University.
He received his medical degree (M.D.) and a Doctor of Medical Science (D.M.Sc.) degree from the Kitasato University (Japan), a Ph.D. at the University of Iowa, clinical residency training in Otolaryngology at Indiana University, and a clinical fellowship training in Neurotology/Skull base surgery at the University of California San Diego. Dr. Matsuoka’s research focuses on regenerative engineering using human pluripotent stem cells in the auditory and vestibular systems. He has won several research awards and is the author of over 50 scientific medical peer-reviewed publications.
Dr. Namro Redwan holds a PhD degree in Chemistry with emphasis on Medicinal/Organic Chemistry from the University of Gothenburg. She obtained her Postdoctoral training in Chemical Biology at the Gladstone Institutes in San Francisco. She was an Assistant Professor at the Clinical Chemistry and Transfusion Medicine at the University of Gotehnburg prior to joining CELLINK as a Senior Principal Scientist/Scientific Officer. Today, Itedale is the Chief Scientific Officer, currently leading the Science and Applications team in the R&D department at CELLINK.
CELLINK is the world leading Bioprinting company and Itedale´s team has commercialized 45+ bioinks and published 15+ application notes in the field of Biofabrication.
Dr. Stefan R. Schmidt MBA currently serves as COO/Head of Operations at BioAtrium AG, a joint venture of Lonza and Sanofi in Visp, Switzerland. Previously he held the position as CSO and other senior executive roles at Rentschler Biopharma, Germany with overall responsibilities for biologics development and manufacturing. Before that, he was CSO at ERA Biotech in Barcelona, Spain, directing the company’s R&D efforts based on fusion proteins. Prior to that, he worked at AstraZeneca in Sweden where he led the unit of Protein Sciences within Global Protein Science & Supply as Associate Director. He started his leadership career 25 years ago at Biotech companies in Munich, Germany where he built up protein biochemistry teams for Connex and GPC-Biotech. He holds a PhD in Biochemistry from the Julius Maximilians University in Wuerzburg, Germany and a MBA from the University in Gävle, Sweden.
More information soon!
More information soon!